IBEX:NASDAQIBEX Limited Analysis

IBEX Limited trades at $32.05, notably below its DCF‑derived fair value of $57.22, implying roughly a 17% upside. Valuation metrics such as a trailing P/E of 10x versus an industry average of 39x and a forward P/E of 8.8x underscore the stock’s cheapness. The company posted 16.8% revenue growth, a robust ROE of 33%, and generated $31.9M in free cash flow, indicating strong operational fundamentals. Technicals are supportive: price sits above the 20‑day (29.88) and 50‑day (28.79) SMAs, the MACD histogram is positive, and RSI is at 63, suggesting modest bullish momentum while staying clear of extreme overbought levels. However, volatility remains high at 53% over the past month and beta hovers around 1.0, reflecting market‑wide risk exposure. The stock finds support near $27.26 and faces resistance around $33.58, a range that aligns with recent price action. Recent Q3 FY2026 earnings calls reaffirmed guidance and highlighted continued demand across its CX service platforms. Overall, the blend of deep valuation discount, solid growth, and favorable cash generation supports a positive outlook despite elevated short‑term volatility.